MoneyWorks4Me

Venus Remedies registers with DSIR to avail custom duty exemption

14 Sep 2023 Evaluate

Venus Remedies has made registration with Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Government of India. This significant milestone allows the company to avail custom duty exemption, reinforcing its commitment to innovation, excellence in research, and its substantial contributions to the healthcare sector.

This registration with DSIR exemplifies Venus Remedies' dedication to fostering innovation and making healthcare solutions more accessible. With a strong track record of brining 15 patented products to market and a robust pipeline of innovative pharmaceuticals, the company has consistently demonstrated a forward-thinking approach to drug development.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..